Print Page  Close Window    

Investor Relations Home

Corporate Profile

La Jolla Pharmaceutical Company is a publicly traded biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases.

Featured Documents

04/11/17Corporate Presentation

Share Price

Stock chart for: LJPC.OQ.  Currently trading at $30.85 with a 52 week high of $39.26 and a 52 week low of $14.65.
Price$30.85
Change (%) Stock is Down 1.43 (4.43%)
Volume24,211
Data as of 07/28/17 10:11 a.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.


Upcoming Events




There are currently no events scheduled.

Recent News


La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress

07/27/17

SAN DIEGO--(BUSINESS WIRE)--Jul. 27, 2017-- La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patien

Read More

Results of ATHOS-3 Phase 3 Study of LJPC-501 Published in The New England Journal of Medicine

05/21/17

SAN DIEGO--(BUSINESS WIRE)--May 21, 2017-- La Jolla Pharmaceutical Company (Nasdaq: LJPC) (La Jolla) today announced that results of the ATHOS-3 (Angiotensin II for the Treatment of High-Output Shock) Phase 3 study of LJPC

Read More

La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress

04/27/17

SAN DIEGO--(BUSINESS WIRE)--Apr. 27, 2017-- La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patien

Read More